ISOPI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 457
EU - Europa 287
AS - Asia 71
SA - Sud America 5
OC - Oceania 3
Totale 823
Nazione #
US - Stati Uniti d'America 444
IT - Italia 95
SE - Svezia 52
IE - Irlanda 50
CN - Cina 31
UA - Ucraina 19
FR - Francia 16
CA - Canada 13
DE - Germania 12
GB - Regno Unito 11
TR - Turchia 9
BE - Belgio 8
RU - Federazione Russa 8
SG - Singapore 8
VN - Vietnam 6
BR - Brasile 5
IN - India 5
IR - Iran 4
KR - Corea 4
NL - Olanda 4
AU - Australia 3
FI - Finlandia 3
ES - Italia 2
IL - Israele 2
JP - Giappone 2
PL - Polonia 2
CZ - Repubblica Ceca 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 823
Città #
Chandler 107
Dublin 49
Ann Arbor 40
Ashburn 37
Jacksonville 32
Princeton 28
Chieti 25
Dearborn 21
Houston 17
Montreal 13
New York 11
Altamura 10
Boardman 10
Rome 10
Wilmington 10
San Mateo 9
San Vito Chietino 9
Brussels 8
Washington 8
Woodbridge 8
Beijing 6
Dong Ket 6
Nanjing 6
Izmir 4
Jiaxing 4
Jundiaí 4
Napoli 4
Rochester 4
Singapore 4
Southend 4
Los Angeles 3
Saint-Saens 3
Amsterdam 2
Aprilia 2
Augusta 2
Cambridge 2
Milan 2
Nanchang 2
Ness Ziona 2
Phoenix 2
Redwood City 2
Rouen 2
San Cristóbal de La Laguna 2
Sinalunga 2
Tianjin 2
Tokyo 2
Woburn 2
Adelaide 1
Antalya 1
Baotou 1
Bari 1
Belgrade 1
Cachan 1
Changsha 1
Charlotte 1
Clifton 1
Collecorvino 1
Denver 1
Edinburgh 1
Giresun 1
Haikou 1
Hebei 1
Heidelberg 1
Helsinki 1
Hoffman 1
Hwaseong-si 1
Jinan 1
Jinhua 1
Kunming 1
Kurrara 1
Lanciano 1
Lanzhou 1
Lappeenranta 1
Lisbon 1
Munich 1
Ningbo 1
Norwalk 1
Oslo 1
Paris 1
Pescara 1
Piotrkow Trybunalski 1
Pittsburgh 1
Prague 1
Prato 1
Pyatigorsk 1
Rio de Janeiro 1
San Salvo 1
Santa Clara 1
Scarlino 1
Seattle 1
Shaoxing 1
Spring 1
Sydney 1
Warsaw 1
Totale 591
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 160
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 124
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 74
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 74
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 72
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 68
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 68
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 63
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 55
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 53
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 52
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 42
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 29
Totale 934
Categoria #
all - tutte 3.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020115 29 4 1 1 11 14 22 5 2 7 15 4
2020/2021139 3 8 13 7 10 15 8 5 30 17 11 12
2021/2022133 5 7 1 28 9 1 4 11 6 6 22 33
2022/2023257 20 36 19 34 24 37 10 22 30 5 9 11
2023/2024184 5 6 11 9 14 37 18 25 6 23 16 14
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 934